Extended indication for Monofer
Monofer (iron isomaltoside; Pharmacosmos) is now indicated for adult patients with iron deficiency when either oral iron preparations are ineffective or cannot be used, or where there is a clinical need to deliver iron over a short duration. The updated summary of product characteristics (SPC) now also states that doses up to 1000mg should be administered over more than 15 minutes, and doses exceeding 1000mg must be administered over 30 minutes or more. Further changes to the SPC reflect these additions.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20200406
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com